Search Results for “” – Page 48 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

1306 Publications found

C-reactive protein- and clinical symptoms-guided strategy in term neonates with early-onset sepsis reduced antibiotic use and hospital stay: a quality improvement initiative.

b

BMC pediatrics

November 20, 2020

p Antibiotic Guidance

c Change patient management Clinical outcomes Observational Operational efficiencies
The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism.

b

International journal of neonatal screening

November 20, 2020

p Newborn Screening

c Economics Model
Feasibility and acceptability of implementing early infant diagnosis of HIV in Papua New Guinea at the point of care: a qualitative exploration of health worker and key informant perspectives.

b

BMJ open

November 19, 2020

p HIV POCT

c Observational Operational efficiencies
Effects of primary care C-reactive protein point-of-care testing on antibiotic prescribing by general practice staff: pragmatic randomised controlled trial, England, 2016 and 2017.

b

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

November 1, 2020

p Antibiotic Guidance

c Change patient management Cluster RCT Patient-centeredness
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.

b

JAMA cardiology

November 1, 2020

p Cardiovascular Disease

c Change patient management Highlighted RCT
Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and decision tree analysis.

b

Journal of medical virology

November 1, 2020

p Cardiovascular Disease

c Clinical outcomes Meta-analysis Review
Cost-effectiveness of adoption strategies for point of care HIV viral load monitoring in South Africa.

b

EClinicalMedicine

November 1, 2020

p HIV POCT

c Economics Model
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles.

b

JCO precision oncology

November 1, 2020

p Cancer

c Change patient management Clinical outcomes Observational
Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult Oncology.

b

JCO precision oncology

November 1, 2020

p Cancer

c Change patient management Guide Policy Making Observational
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial.

b

The Lancet. Respiratory medicine

November 1, 2020

p Cancer

c Change patient management Clinical outcomes RCT